Tumor Microenvironment Features as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors (ICI) in Metastatic Clear Cell Renal Cell Carcinoma (mccRCC)

SIMPLE SUMMARY: In recent years, the therapeutic armamentarium of mccRCC has changed dramatically with the emergence of targeted therapy and immune checkpoint inhibitors, used alone or as a combination. However, mccRCC still have a poor prognosis and a significant portion of patients experience prim...

Descripción completa

Detalles Bibliográficos
Autores principales: Simonaggio, Audrey, Epaillard, Nicolas, Pobel, Cédric, Moreira, Marco, Oudard, Stéphane, Vano, Yann-Alexandre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827724/
https://www.ncbi.nlm.nih.gov/pubmed/33435262
http://dx.doi.org/10.3390/cancers13020231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827724/
https://www.ncbi.nlm.nih.gov/pubmed/33435262
http://dx.doi.org/10.3390/cancers13020231

Ejemplares similares